Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 332 results in range #501 to #832.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. ICRP Publication 149‏‎ (1 revision)
  2. ICRP Publication 23‏‎ (1 revision)
  3. DRL quantity‏‎ (1 revision)
  4. ICRP Publication 30 (Supplement to Part 2)‏‎ (1 revision)
  5. Detector quantum efficiency‏‎ (1 revision)
  6. ICRP Publication 97‏‎ (1 revision)
  7. ICRP Publication 45‏‎ (1 revision)
  8. Secretory cells‏‎ (1 revision)
  9. ICRP Publication 6‏‎ (1 revision)
  10. Intensity-modulated radiotherapy‏‎ (1 revision)
  11. ICRP Publication 74‏‎ (1 revision)
  12. Stem cell‏‎ (1 revision)
  13. Kerma approximation‏‎ (1 revision)
  14. ICRP Publication 89‏‎ (1 revision)
  15. Exogenous excretion‏‎ (1 revision)
  16. 1931 Recommendations‏‎ (1 revision)
  17. National radon survey‏‎ (1 revision)
  18. Adenoma‏‎ (1 revision)
  19. Potential alpha energy concentration‏‎ (1 revision)
  20. ICRP Publication 107‏‎ (1 revision)
  21. ICRP Publication 120‏‎ (1 revision)
  22. Carers and comforters‏‎ (1 revision)
  23. ICRP Publication 135‏‎ (1 revision)
  24. ICRP Publication 15‏‎ (1 revision)
  25. Redox‏‎ (1 revision)
  26. ICRP Publication 24‏‎ (1 revision)
  27. Relative biological effectiveness‏‎ (1 revision)
  28. ICRP Publication 31‏‎ (1 revision)
  29. Deterministic effect‏‎ (1 revision)
  30. ICRP Publication 98‏‎ (1 revision)
  31. ICRP Publication 46‏‎ (1 revision)
  32. ICRP Publication 60‏‎ (1 revision)
  33. Dose modifying factor‏‎ (1 revision)
  34. Somatic effect‏‎ (1 revision)
  35. ICRP Publication 75‏‎ (1 revision)
  36. ICRP Publication 9‏‎ (1 revision)
  37. Targeted effects‏‎ (1 revision)
  38. 1934 Recommendations‏‎ (1 revision)
  39. Access control‏‎ (1 revision)
  40. Typical value‏‎ (1 revision)
  41. General Information: Radon‏‎ (1 revision - redirect page)
  42. Particle transport‏‎ (1 revision)
  43. ICRP Publication 108‏‎ (1 revision)
  44. Brachytherapy‏‎ (1 revision)
  45. ICRP Publication 121‏‎ (1 revision)
  46. Case–control study‏‎ (1 revision)
  47. ICRP Publication 136‏‎ (1 revision)
  48. Collective dose‏‎ (1 revision)
  49. ICRP Publication 150‏‎ (1 revision)
  50. ICRP Publication 25‏‎ (1 revision)
  51. ICRP Publication 26‏‎ (1 revision)
  52. DS86‏‎ (1 revision)
  53. Relative life lost‏‎ (1 revision)
  54. ICRP Publication 32‏‎ (1 revision)
  55. ICRP Publication 99‏‎ (1 revision)
  56. ICRP Publication 47‏‎ (1 revision)
  57. Security screening‏‎ (1 revision)
  58. ICRP Publication 61‏‎ (1 revision)
  59. ICRP Publication 76‏‎ (1 revision)
  60. Stochastic effect‏‎ (1 revision)
  61. Equilibrium equivalent concentration‏‎ (1 revision)
  62. Expanded radiation field‏‎ (1 revision)
  63. 1937 Recommendations‏‎ (1 revision)
  64. Tolerance dose‏‎ (1 revision)
  65. Adventitious source‏‎ (1 revision)
  66. Occupancy factor‏‎ (1 revision)
  67. Annual intake‏‎ (1 revision)
  68. ICRP Publication 109‏‎ (1 revision)
  69. ICRP Publication 122‏‎ (1 revision)
  70. ICRP Publication 137‏‎ (1 revision)
  71. Radon-prone area‏‎ (1 revision)
  72. ICRP Publication 151‏‎ (1 revision)
  73. Reference Person‏‎ (1 revision)
  74. ICRP Publication 27‏‎ (1 revision)
  75. Relative risk‏‎ (1 revision)
  76. ICRP Publication 33‏‎ (1 revision)
  77. Detriment-adjusted risk‏‎ (1 revision)
  78. Ring chromosome‏‎ (1 revision)
  79. ICRP Supporting Guidance 2‏‎ (1 revision)
  80. ICRP Publication 48‏‎ (1 revision)
  81. Dose-response function‏‎ (1 revision)
  82. ICRP Publication 62‏‎ (1 revision)
  83. International Commission on Radiological Protection‏‎ (1 revision)
  84. ICRP Publication 77‏‎ (1 revision)
  85. Lag‏‎ (1 revision)
  86. Equilibrium factor‏‎ (1 revision)
  87. Teratocarcinoma‏‎ (1 revision)
  88. Low dose‏‎ (1 revision)
  89. 1950 Recommendations‏‎ (1 revision)
  90. Backscatter factor‏‎ (1 revision)
  91. Potentially lethal damage repair‏‎ (1 revision)
  92. ICRP Publication 10A‏‎ (1 revision)
  93. ICRP Publication 123‏‎ (1 revision)
  94. Charged-particle equilibrium‏‎ (1 revision)
  95. ICRP Publication 138‏‎ (1 revision)
  96. Collimation‏‎ (1 revision)
  97. ICRP Publication 152‏‎ (1 revision)
  98. ICRP Publication 28‏‎ (1 revision)
  99. Relative survival‏‎ (1 revision)
  100. ICRP Publication 34‏‎ (1 revision)
  101. ICRP Publication 49‏‎ (1 revision)
  102. ICRP Publication 63‏‎ (1 revision)
  103. Source region‏‎ (1 revision)
  104. ICRP Publication 78‏‎ (1 revision)
  105. Elemental dose‏‎ (1 revision)
  106. Late normal tissue responses‏‎ (1 revision)
  107. Exposed individuals‏‎ (1 revision)
  108. 1954 Recommendations‏‎ (1 revision)
  109. Α/β value‏‎ (1 revision)
  110. Oncogene‏‎ (1 revision)
  111. Apoptosis‏‎ (1 revision)
  112. ICRP Publication 11‏‎ (1 revision)
  113. ICRP Publication 124‏‎ (1 revision)
  114. ICRP Publication 139‏‎ (1 revision)
  115. ICRP Publication 153‏‎ (1 revision)
  116. ICRP Publication 29‏‎ (1 revision)
  117. ICRP Publication 35‏‎ (1 revision)
  118. ICRP Publication 5‏‎ (1 revision)
  119. Dose-threshold hypothesis‏‎ (1 revision)
  120. Severe deterministic injury‏‎ (1 revision)
  121. ICRP Publication 64‏‎ (1 revision)
  122. Intervention‏‎ (1 revision)
  123. ICRP Publication 79‏‎ (1 revision)
  124. Sublethal damage repair‏‎ (1 revision)
  125. 1956 Recommendations‏‎ (1 revision)
  126. Transfer of risk‏‎ (1 revision)
  127. Molecular imaging‏‎ (1 revision)
  128. Activation‏‎ (1 revision)
  129. Noise‏‎ (1 revision)
  130. ΓH2AX foci‏‎ (1 revision)
  131. Operating management‏‎ (1 revision)
  132. Pencil beam‏‎ (1 revision)
  133. ICRP Publication 1‏‎ (1 revision)
  134. Baseline disease rates‏‎ (1 revision)
  135. Practice‏‎ (1 revision)
  136. ICRP Publication 110‏‎ (1 revision)
  137. Breakpoint cluster region/abelson‏‎ (1 revision)
  138. ICRP Publication 125‏‎ (1 revision)
  139. ICRP Publication 14‏‎ (1 revision)
  140. Commissioning‏‎ (1 revision)
  141. ICRP Publication 154‏‎ (1 revision)
  142. Cosmic radiation‏‎ (1 revision)
  143. ICRP Publication 3‏‎ (1 revision)
  144. ICRP Publication 36‏‎ (1 revision)
  145. Dicentric chromosome‏‎ (1 revision)
  146. Risk model‏‎ (1 revision)
  147. ICRP Publication 50‏‎ (1 revision)
  148. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  149. Sheltering‏‎ (1 revision)
  150. Induced genomic instability‏‎ (1 revision)
  151. ICRP Publication 65‏‎ (1 revision)
  152. ICRP Publication 8‏‎ (1 revision)
  153. Licensee‏‎ (1 revision)
  154. Thermodynamic diameter‏‎ (1 revision)
  155. Low linear energy transfer radiation‏‎ (1 revision)
  156. 1959 Decisions‏‎ (1 revision)
  157. Nominal risk coefficient‏‎ (1 revision)
  158. Hereditary effect‏‎ (1 revision)
  159. ICRP Publication 10‏‎ (1 revision)
  160. ICRP Publication 111‏‎ (1 revision)
  161. Quality control testing‏‎ (1 revision)
  162. ICRP Publication 126‏‎ (1 revision)
  163. Radioactive waste‏‎ (1 revision)
  164. ICRP Publication 140‏‎ (1 revision)
  165. ICRP Publication 155‏‎ (1 revision)
  166. ICRP Publication 30‏‎ (1 revision)
  167. Dental and maxillofacial imaging‏‎ (1 revision)
  168. ICRP Publication 37‏‎ (1 revision)
  169. ICRPædia Guide to Radiological Protection in Healthcare‏‎ (1 revision - redirect page)
  170. ICRP Publication 51‏‎ (1 revision)
  171. Shielding‏‎ (1 revision)
  172. ICRP Publication 66‏‎ (1 revision)
  173. ICRP Publication 80‏‎ (1 revision)
  174. Superposition principle‏‎ (1 revision)
  175. Life Span Study‏‎ (1 revision)
  176. Thoracic airways‏‎ (1 revision)
  177. Multifactorial diseases‏‎ (1 revision)
  178. Active detection system‏‎ (1 revision)
  179. Nominal value‏‎ (1 revision)
  180. ICRP Publication 100‏‎ (1 revision)
  181. ICRP Publication 112‏‎ (1 revision)
  182. ICRP Publication 127‏‎ (1 revision)
  183. ICRP Publication 141‏‎ (1 revision)
  184. ICRP Publication 16‏‎ (1 revision)
  185. ICRP Publication 30 (Index)‏‎ (1 revision)
  186. ICRP Publication 38‏‎ (1 revision)
  187. ICRP Publication 52‏‎ (1 revision)
  188. Dose commitment‏‎ (1 revision)
  189. ICRP Publication 67‏‎ (1 revision)
  190. Doubling dose‏‎ (1 revision)
  191. ICRP Publication 81‏‎ (1 revision)
  192. Supervised area‏‎ (1 revision)
  193. Evacuation‏‎ (1 revision)
  194. Thoron progeny‏‎ (1 revision)
  195. Exposure index‏‎ (1 revision)
  196. AML/eto‏‎ (1 revision)
  197. Transgenerational effect‏‎ (1 revision)
  198. Frequent flyer‏‎ (1 revision)
  199. Non-homologous end joining‏‎ (1 revision)
  200. Optimisation of protection‏‎ (1 revision)
  201. Attributable risk‏‎ (1 revision)
  202. ICRP Publication 101‏‎ (1 revision)
  203. Best available techniques‏‎ (1 revision)
  204. ICRP Publication 113‏‎ (1 revision)
  205. Bronchiolar region‏‎ (1 revision)
  206. Quasi-threshold dose‏‎ (1 revision)
  207. ICRP Publication 128‏‎ (1 revision)
  208. ICRP Publication 142‏‎ (1 revision)
  209. Compartment‏‎ (1 revision)
  210. Radon progeny‏‎ (1 revision)
  211. ICRP Publication 17‏‎ (1 revision)
  212. Count median diameter‏‎ (1 revision)
  213. Reference parameter value‏‎ (1 revision)
  214. ICRP Publication 30 (Part 1)‏‎ (1 revision)
  215. Deposition‏‎ (1 revision)
  216. ICRP Publication 90‏‎ (1 revision)
  217. ICRP Publication 39‏‎ (1 revision)
  218. Digital breast tomosynthesis‏‎ (1 revision)
  219. ICRP Publication 53‏‎ (1 revision)
  220. Size-specific dose estimate‏‎ (1 revision)
  221. ICRP Publication 68‏‎ (1 revision)
  222. Specific absorbed fraction‏‎ (1 revision)
  223. ICRP Publication 82‏‎ (1 revision)
  224. Surface contamination‏‎ (1 revision)
  225. Excess absolute risk‏‎ (1 revision)
  226. Exposure pathway‏‎ (1 revision)
  227. Translocation‏‎ (1 revision)
  228. Multistage carcinogenesis model‏‎ (1 revision)
  229. Functional subunits‏‎ (1 revision)
  230. Activity median aerodynamic diameter‏‎ (1 revision)
  231. Ground-level enhancement‏‎ (1 revision)
  232. Phantom‏‎ (1 revision)
  233. ICRP Publication 101a‏‎ (1 revision)
  234. ICRP Publication 114‏‎ (1 revision)
  235. ICRP Publication 129‏‎ (1 revision)
  236. ICRP Publication 143‏‎ (1 revision)
  237. Compartment (environmental)‏‎ (1 revision)
  238. Ras‏‎ (1 revision)
  239. ICRP Publication 18‏‎ (1 revision)
  240. Cross section‏‎ (1 revision)
  241. Reference phantom‏‎ (1 revision)
  242. ICRP Publication 30 (Part 2)‏‎ (1 revision)
  243. ICRP Publication 91‏‎ (1 revision)
  244. ICRP Publication 4‏‎ (1 revision)
  245. ICRP Publication 54‏‎ (1 revision)
  246. Slice‏‎ (1 revision)
  247. ICRP Publication 69‏‎ (1 revision)
  248. ICRP Publication 83‏‎ (1 revision)
  249. Threshold level‏‎ (1 revision)
  250. Organ at risk‏‎ (1 revision)
  251. Homologous recombination‏‎ (1 revision)
  252. Authorised discharge‏‎ (1 revision)
  253. ICRP Publication 101b‏‎ (1 revision)
  254. Principles of protection‏‎ (1 revision)
  255. ICRP Publication 115‏‎ (1 revision)
  256. Radiation-induced second cancer‏‎ (1 revision)
  257. ICRP Publication 13‏‎ (1 revision)
  258. Clinical audit‏‎ (1 revision)
  259. ICRP Publication 144‏‎ (1 revision)
  260. Rb‏‎ (1 revision)
  261. ICRP Publication 19‏‎ (1 revision)
  262. Reference value‏‎ (1 revision)
  263. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  264. Derived consideration reference level‏‎ (1 revision)
  265. ICRP Publication 92‏‎ (1 revision)
  266. ICRP Publication 40‏‎ (1 revision)
  267. ICRP Publication 55‏‎ (1 revision)
  268. Dose conversion convention‏‎ (1 revision)
  269. Informed consent‏‎ (1 revision)
  270. ICRP Publication 7‏‎ (1 revision)
  271. Spongiosa‏‎ (1 revision)
  272. ICRP Publication 84‏‎ (1 revision)
  273. Exclusion‏‎ (1 revision)
  274. Marrow cellularity‏‎ (1 revision)
  275. Multitarget equation‏‎ (1 revision)
  276. Acute exposure‏‎ (1 revision)
  277. Allometry‏‎ (1 revision)
  278. Pilomatricoma‏‎ (1 revision)
  279. ICRP Publication 102‏‎ (1 revision)
  280. ICRP Publication 116‏‎ (1 revision)
  281. Radiation-induced secondary malignancy‏‎ (1 revision)
  282. ICRP Publication 130‏‎ (1 revision)
  283. Radiological attack‏‎ (1 revision)
  284. ICRP Publication 145‏‎ (1 revision)
  285. Reactive oxygen species‏‎ (1 revision)
  286. ICRP Publication 2‏‎ (1 revision)
  287. Reference worker‏‎ (1 revision)
  288. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  289. Derived investigation level‏‎ (1 revision)
  290. ICRP Publication 93‏‎ (1 revision)
  291. ICRP Publication 41‏‎ (1 revision)
  292. Directional dose equivalent‏‎ (1 revision)
  293. ICRU 4-element tissue‏‎ (1 revision)
  294. ICRP Publication 56‏‎ (1 revision)
  295. Dose conversion factor‏‎ (1 revision)
  296. ICRP Publication 70‏‎ (1 revision)
  297. Effect modifier‏‎ (1 revision)
  298. ICRP Publication 85‏‎ (1 revision)
  299. Endosteum‏‎ (1 revision)
  300. System of radiological protection‏‎ (1 revision)
  301. Time-resolved computed tomography‏‎ (1 revision)
  302. Mutation component‏‎ (1 revision)
  303. Waste management‏‎ (1 revision)
  304. Normal tissue complication probability‏‎ (1 revision)
  305. Biological half-life‏‎ (1 revision)
  306. ICRP Publication 117‏‎ (1 revision)
  307. ICRP Publication 131‏‎ (1 revision)
  308. Radiological controlled area‏‎ (1 revision)
  309. ICRP Publication 146‏‎ (1 revision)
  310. Concentration ratio‏‎ (1 revision)
  311. ICRP Publication 20‏‎ (1 revision)
  312. Referrer‏‎ (1 revision)
  313. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  314. Derived limit‏‎ (1 revision)
  315. ICRP Publication 94‏‎ (1 revision)
  316. ICRP Publication 42‏‎ (1 revision)
  317. ICRU sphere‏‎ (1 revision)
  318. ICRP Publication 57‏‎ (1 revision)
  319. ICRP Publication 71‏‎ (1 revision)
  320. ICRP Publication 86‏‎ (1 revision)
  321. Treatment preparation in radiotherapy‏‎ (1 revision)
  322. Notification value‏‎ (1 revision)
  323. Other (systemic) tissues‏‎ (1 revision)
  324. Human Alimentary Tract Model‏‎ (1 revision)
  325. ICRP Publication 104‏‎ (1 revision)
  326. Biomarker‏‎ (1 revision)
  327. ICRP Publication 132‏‎ (1 revision)
  328. Clonogenic surviving fraction‏‎ (1 revision)
  329. ICRP Publication 147‏‎ (1 revision)
  330. Cone beam computed tomography‏‎ (1 revision)
  331. ICRP Publication 21‏‎ (1 revision)
  332. Region‏‎ (1 revision)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:MostRevisions"